Home

Headache

Read time: 3 min

What do patients want and expect from their treatment for depression?

How aligned are treatment expectations between clinicians and patients? Even in the era of...

Read time: 3 min

The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients

Patients with FEP often ask whether they can discontinue their medication after a period of...

Read time: 3 min

Innovation and tailored treatments drive improved outcomes in depression

We are a step closer to the early detection of antidepressant treatment failure, a paradigm shift...

Read time: 3 min

Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden

One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and 70...

Parkinson's Disease

Read time: 5 min

Biomarkers – ever closer in PD

For some time now, researchers have been seeking effective biomarkers for the diagnosis and...

Read time: 5 min

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...

Depression, Schizophrenia

Read time: 3 min

The evolving science of psychiatry

Science is beginning to reinforce the practice of psychiatry through increasing understanding of...

Parkinson's Disease

Read time: 4 min

Biometrics – when, how and why

MDS has for the first time chosen as its main conference theme a topic outside its main remit of...

Read time: 1 min

Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...

Read time: 4 min

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Slide library - The Lundbeck Institute Campus

Comorbidity - New Slides for Schizophrenia now available

Parkinson's Disease

Read time: 4 min

Epigenetic adventures in alpha-synuclein transcription

Thirty years ago, most of the genome was described as junk – useless relics of evolution. How...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country